Global Antifungal Drugs Market Growth 2020-2025

November 2020 | 158 pages | ID: G9C8395C026AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, over the next five years the Antifungal Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antifungal Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Antifungal Drugs market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Antifungal Drugs, covering the supply chain analysis, impact assessment to the Antifungal Drugs market size growth rate in several scenarios, and the measures to be undertaken by Antifungal Drugs companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

• Azoles
• Echinocandins
• Polyenes
• Allylamines
• Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

• Dermatophytosis
• Aspergillosis
• Candidiasis
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Novartis
• J & J
• Pfizer
• Merck
• Enzon Pharmaceuticals
• Sanofi
• GlaxoSmithKline
• Bayer
• Abbott
• Astellas Pharma
• Teva
• Mylan

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Antifungal Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Antifungal Drugs market by identifying its various subsegments.
• Focuses on the key global Antifungal Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Antifungal Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Antifungal Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antifungal Drugs Consumption 2015-2025
  2.1.2 Antifungal Drugs Consumption CAGR by Region
2.2 Antifungal Drugs Segment by Type
  2.2.1 Azoles
  2.2.2 Echinocandins
  2.2.3 Polyenes
  2.2.4 Allylamines
  2.2.5 Others
2.3 Antifungal Drugs Consumption by Type
  2.3.1 Global Antifungal Drugs Consumption Market Share by Type (2015-2020)
  2.3.2 Global Antifungal Drugs Revenue and Market Share by Type (2015-2020)
  2.3.3 Global Antifungal Drugs Sale Price by Type (2015-2020)
2.4 Antifungal Drugs Segment by Application
  2.4.1 Dermatophytosis
  2.4.2 Aspergillosis
  2.4.3 Candidiasis
  2.4.4 Others
2.5 Antifungal Drugs Consumption by Application
  2.5.1 Global Antifungal Drugs Consumption Market Share by Type (2015-2020)
  2.5.2 Global Antifungal Drugs Value and Market Share by Type (2015-2020)
  2.5.3 Global Antifungal Drugs Sale Price by Type (2015-2020)

3 GLOBAL ANTIFUNGAL DRUGS BY COMPANY

3.1 Global Antifungal Drugs Sales Market Share by Company
  3.1.1 Global Antifungal Drugs Sales by Company (2018-2020)
  3.1.2 Global Antifungal Drugs Sales Market Share by Company (2018-2020)
3.2 Global Antifungal Drugs Revenue Market Share by Company
  3.2.1 Global Antifungal Drugs Revenue by Company (2018-2020)
  3.2.2 Global Antifungal Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Antifungal Drugs Sale Price by Company
3.4 Global Antifungal Drugs Manufacturing Base Distribution, Sales Area, Type by Company
  3.4.1 Global Antifungal Drugs Manufacturing Base Distribution and Sales Area by Company
  3.4.2 Players Antifungal Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ANTIFUNGAL DRUGS BY REGIONS

4.1 Antifungal Drugs by Regions
4.2 Americas Antifungal Drugs Consumption Growth
4.3 APAC Antifungal Drugs Consumption Growth
4.4 Europe Antifungal Drugs Consumption Growth
4.5 Middle East & Africa Antifungal Drugs Consumption Growth

5 AMERICAS

5.1 Americas Antifungal Drugs Consumption by Countries
  5.1.1 Americas Antifungal Drugs Consumption by Countries (2015-2020)
  5.1.2 Americas Antifungal Drugs Value by Countries (2015-2020)
5.2 Americas Antifungal Drugs Consumption by Type
5.3 Americas Antifungal Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Antifungal Drugs Consumption by Regions
  6.1.1 APAC Antifungal Drugs Consumption by Regions (2015-2020)
  6.1.2 APAC Antifungal Drugs Value by Regions (2015-2020)
6.2 APAC Antifungal Drugs Consumption by Type
6.3 APAC Antifungal Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 EUROPE

7.1 Europe Antifungal Drugs by Countries
  7.1.1 Europe Antifungal Drugs Consumption by Countries (2015-2020)
  7.1.2 Europe Antifungal Drugs Value by Countries (2015-2020)
7.2 Europe Antifungal Drugs Consumption by Type
7.3 Europe Antifungal Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antifungal Drugs by Countries
  8.1.1 Middle East & Africa Antifungal Drugs Consumption by Countries (2015-2020)
  8.1.2 Middle East & Africa Antifungal Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Antifungal Drugs Consumption by Type
8.3 Middle East & Africa Antifungal Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Channels
  10.1.2 Indirect Channels
10.2 Antifungal Drugs Distributors
10.3 Antifungal Drugs Customer

11 GLOBAL ANTIFUNGAL DRUGS MARKET FORECAST

11.1 Global Antifungal Drugs Consumption Forecast (2021-2025)
11.2 Global Antifungal Drugs Forecast by Regions
  11.2.1 Global Antifungal Drugs Forecast by Regions (2021-2025)
  11.2.2 Global Antifungal Drugs Value Forecast by Regions (2021-2025)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Antifungal Drugs Forecast by Type
11.8 Global Antifungal Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Novartis
  12.1.1 Company Information
  12.1.2 Antifungal Drugs Product Offered
  12.1.3 Novartis Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.1.4 Main Business Overview
  12.1.5 Novartis Latest Developments
12.2 J & J
  12.2.1 Company Information
  12.2.2 Antifungal Drugs Product Offered
  12.2.3 J & J Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.2.4 Main Business Overview
  12.2.5 J & J Latest Developments
12.3 Pfizer
  12.3.1 Company Information
  12.3.2 Antifungal Drugs Product Offered
  12.3.3 Pfizer Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.3.4 Main Business Overview
  12.3.5 Pfizer Latest Developments
12.4 Merck
  12.4.1 Company Information
  12.4.2 Antifungal Drugs Product Offered
  12.4.3 Merck Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.4.4 Main Business Overview
  12.4.5 Merck Latest Developments
12.5 Enzon Pharmaceuticals
  12.5.1 Company Information
  12.5.2 Antifungal Drugs Product Offered
  12.5.3 Enzon Pharmaceuticals Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.5.4 Main Business Overview
  12.5.5 Enzon Pharmaceuticals Latest Developments
12.6 Sanofi
  12.6.1 Company Information
  12.6.2 Antifungal Drugs Product Offered
  12.6.3 Sanofi Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.6.4 Main Business Overview
  12.6.5 Sanofi Latest Developments
12.7 GlaxoSmithKline
  12.7.1 Company Information
  12.7.2 Antifungal Drugs Product Offered
  12.7.3 GlaxoSmithKline Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.7.4 Main Business Overview
  12.7.5 GlaxoSmithKline Latest Developments
12.8 Bayer
  12.8.1 Company Information
  12.8.2 Antifungal Drugs Product Offered
  12.8.3 Bayer Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.8.4 Main Business Overview
  12.8.5 Bayer Latest Developments
12.9 Abbott
  12.9.1 Company Information
  12.9.2 Antifungal Drugs Product Offered
  12.9.3 Abbott Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.9.4 Main Business Overview
  12.9.5 Abbott Latest Developments
12.10 Astellas Pharma
  12.10.1 Company Information
  12.10.2 Antifungal Drugs Product Offered
  12.10.3 Astellas Pharma Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.10.4 Main Business Overview
  12.10.5 Astellas Pharma Latest Developments
12.11 Teva
  12.11.1 Company Information
  12.11.2 Antifungal Drugs Product Offered
  12.11.3 Teva Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.11.4 Main Business Overview
  12.11.5 Teva Latest Developments
12.12 Mylan
  12.12.1 Company Information
  12.12.2 Antifungal Drugs Product Offered
  12.12.3 Mylan Antifungal Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.12.4 Main Business Overview
  12.12.5 Mylan Latest Developments

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Research Methodology
Table 2. Data Source
Table 3. Antifungal Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Azoles
Table 5. Major Players of Echinocandins
Table 6. Major Players of Polyenes
Table 7. Major Players of Allylamines
Table 8. Major Players of Others
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Antifungal Drugs Consumption Market Share by Type (2015-2020)
Table 11. Global Antifungal Drugs Revenue by Type (2015-2020) ($ million)
Table 12. Global Antifungal Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Antifungal Drugs Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Antifungal Drugs Consumption Market Share by Application (2015-2020)
Table 16. Global Antifungal Drugs Value by Application (2015-2020)
Table 17. Global Antifungal Drugs Value Market Share by Application (2015-2020)
Table 18. Global Antifungal Drugs Sale Price by Application (2015-2020)
Table 19. Global Antifungal Drugs Sales by Company (2017-2019) (K Units)
Table 20. Global Antifungal Drugs Sales Market Share by Company (2017-2019)
Table 21. Global Antifungal Drugs Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Antifungal Drugs Revenue Market Share by Company (2017-2019)
Table 23. Global Antifungal Drugs Sale Price by Company (2017-2019)
Table 24. Global Antifungal Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Antifungal Drugs Products Offered
Table 26. Antifungal Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Antifungal Drugs Consumption by Regions 2015-2020 (K Units)
Table 28. Global Antifungal Drugs Consumption Market Share by Regions 2015-2020
Table 29. Global Antifungal Drugs Value by Regions 2015-2020 ($ Millions)
Table 30. Global Antifungal Drugs Value Market Share by Regions 2015-2020
Table 31. Americas Antifungal Drugs Consumption by Countries (2015-2020) (K Units)
Table 32. Americas Antifungal Drugs Consumption Market Share by Countries (2015-2020)
Table 33. Americas Antifungal Drugs Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Antifungal Drugs Value Market Share by Countries (2015-2020)
Table 35. Americas Antifungal Drugs Consumption by Type (2015-2020) (K Units)
Table 36. Americas Antifungal Drugs Consumption Market Share by Type (2015-2020)
Table 37. Americas Antifungal Drugs Consumption by Application (2015-2020) (K Units)
Table 38. Americas Antifungal Drugs Consumption Market Share by Application (2015-2020)
Table 39. APAC Antifungal Drugs Consumption by Regions (2015-2020) (K Units)
Table 40. APAC Antifungal Drugs Consumption Market Share by Regions (2015-2020)
Table 41. APAC Antifungal Drugs Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Antifungal Drugs Value Market Share by Regions (2015-2020)
Table 43. APAC Antifungal Drugs Consumption by Type (2015-2020) (K Units)
Table 44. APAC Antifungal Drugs Consumption Market Share by Type (2015-2020)
Table 45. APAC Antifungal Drugs Consumption by Application (2015-2020) (K Units)
Table 46. APAC Antifungal Drugs Consumption Market Share by Application (2015-2020)
Table 47. Europe Antifungal Drugs Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Antifungal Drugs Consumption Market Share by Countries (2015-2020)
Table 49. Europe Antifungal Drugs Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Antifungal Drugs Value Market Share by Countries (2015-2020)
Table 51. Europe Antifungal Drugs Consumption by Type (2015-2020) (K Units)
Table 52. Europe Antifungal Drugs Consumption Market Share by Type (2015-2020)
Table 53. Europe Antifungal Drugs Consumption by Application (2015-2020) (K Units)
Table 54. Europe Antifungal Drugs Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Antifungal Drugs Consumption by Countries (2015-2020) (K Units)
Table 56. Middle East & Africa Antifungal Drugs Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Antifungal Drugs Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Antifungal Drugs Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Antifungal Drugs Consumption by Type (2015-2020) (K Units)
Table 60. Middle East & Africa Antifungal Drugs Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Antifungal Drugs Consumption by Application (2015-2020) (K Units)
Table 62. Middle East & Africa Antifungal Drugs Consumption Market Share by Application (2015-2020)
Table 63. Antifungal Drugs Distributors List
Table 64. Antifungal Drugs Customer List
Table 65. Global Antifungal Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 66. Global Antifungal Drugs Consumption Market Forecast by Regions
Table 67. Global Antifungal Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Antifungal Drugs Value Market Share Forecast by Regions
Table 69. Global Antifungal Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 70. Global Antifungal Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Antifungal Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Antifungal Drugs Value Market Share Forecast by Type (2021-2025)
Table 73. Global Antifungal Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 74. Global Antifungal Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Antifungal Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Antifungal Drugs Value Market Share Forecast by Application (2021-2025)
Table 77. Novartis Product Offered
Table 78. Novartis Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. Novartis Basic Information, Company Total Revenue (in $ million), Antifungal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. J & J Product Offered
Table 83. J & J Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 84. J & J Main Business
Table 85. J & J Latest Developments
Table 86. J & J Basic Information, Company Total Revenue (in $ million), Antifungal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Product Offered
Table 88. Pfizer Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Pfizer Basic Information, Company Total Revenue (in $ million), Antifungal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck Product Offered
Table 93. Merck Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 94. Merck Main Business
Table 95. Merck Latest Developments
Table 96. Merck Basic Information, Company Total Revenue (in $ million), Antifungal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Enzon Pharmaceuticals Product Offered
Table 98. Enzon Pharmaceuticals Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 99. Enzon Pharmaceuticals Main Business
Table 100. Enzon Pharmaceuticals Latest Developments
Table 101. Enzon Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Antifungal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Sanofi Product Offered
Table 103. Sanofi Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 104. Sanofi Main Business
Table 105. Sanofi Latest Developments
Table 106. Sanofi Basic Information, Company Total Revenue (in $ million), Antifungal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. GlaxoSmithKline Product Offered
Table 108. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Antifungal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. GlaxoSmithKline Main Business
Table 110. GlaxoSmithKline Latest Developments
Table 111. GlaxoSmithKline Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Bayer Product Offered
Table 113. Bayer Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 114. Bayer Main Business
Table 115. Bayer Latest Developments
Table 116. Bayer Basic Information, Company Total Revenue (in $ million), Antifungal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Abbott Product Offered
Table 118. Abbott Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 119. Abbott Main Business
Table 120. Abbott Latest Developments
Table 121. Abbott Basic Information, Company Total Revenue (in $ million), Antifungal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Astellas Pharma Product Offered
Table 123. Astellas Pharma Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 124. Astellas Pharma Main Business
Table 125. Astellas Pharma Latest Developments
Table 126. Astellas Pharma Basic Information, Company Total Revenue (in $ million), Antifungal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Teva Product Offered
Table 128. Teva Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 129. Teva Main Business
Table 130. Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 131. Teva Latest Developments
Table 132. Mylan Product Offered
Table 133. Mylan Antifungal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 134. Mylan Main Business
Table 135. Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. Mylan Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Antifungal Drugs
Figure 2. Antifungal Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Antifungal Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Antifungal Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Azoles
Figure 7. Product Picture of Echinocandins
Figure 8. Product Picture of Polyenes
Figure 9. Product Picture of Allylamines
Figure 10. Product Picture of Others
Figure 11. Global Antifungal Drugs Consumption Market Share by Type (2015-2020)
Figure 12. Global Antifungal Drugs Value Market Share by Type (2015-2020)
Figure 13. Antifungal Drugs Consumed in Dermatophytosis
Figure 14. Global Antifungal Drugs Market: Dermatophytosis (2015-2020) (K Units)
Figure 15. Global Antifungal Drugs Market: Dermatophytosis (2015-2020) ($ Millions)
Figure 16. Antifungal Drugs Consumed in Aspergillosis
Figure 17. Global Antifungal Drugs Market: Aspergillosis (2015-2020) (K Units)
Figure 18. Global Antifungal Drugs Market: Aspergillosis (2015-2020) ($ Millions)
Figure 19. Antifungal Drugs Consumed in Candidiasis
Figure 20. Global Antifungal Drugs Market: Candidiasis (2015-2020) (K Units)
Figure 21. Global Antifungal Drugs Market: Candidiasis (2015-2020) ($ Millions)
Figure 22. Antifungal Drugs Consumed in Others
Figure 23. Global Antifungal Drugs Market: Others (2015-2020) (K Units)
Figure 24. Global Antifungal Drugs Market: Others (2015-2020) ($ Millions)
Figure 25. Global Antifungal Drugs Consumption Market Share by Application (2015-2020)
Figure 26. Global Antifungal Drugs Value Market Share by Application (2015-2020)
Figure 27. Global Antifungal Drugs Sales Market Share by Company in 2017
Figure 28. Global Antifungal Drugs Sales Market Share by Company in 2019
Figure 29. Global Antifungal Drugs Revenue Market Share by Company in 2017
Figure 30. Global Antifungal Drugs Revenue Market Share by Company in 2019
Figure 31. Global Antifungal Drugs Sale Price by Company in 2019
Figure 32. Global Antifungal Drugs Consumption Market Share by Regions 2015-2020
Figure 33. Global Antifungal Drugs Value Market Share by Regions 2015-2020
Figure 34. Americas Antifungal Drugs Consumption 2015-2020 (K Units)
Figure 35. Americas Antifungal Drugs Value 2015-2020 ($ Millions)
Figure 36. APAC Antifungal Drugs Consumption 2015-2020 (K Units)
Figure 37. APAC Antifungal Drugs Value 2015-2020 ($ Millions)
Figure 38. Europe Antifungal Drugs Consumption 2015-2020 (K Units)
Figure 39. Europe Antifungal Drugs Value 2015-2020 ($ Millions)
Figure 40. Middle East & Africa Antifungal Drugs Consumption 2015-2020 (K Units)
Figure 41. Middle East & Africa Antifungal Drugs Value 2015-2020 ($ Millions)
Figure 42. Americas Antifungal Drugs Consumption Market Share by Countries in 2019
Figure 43. Americas Antifungal Drugs Value Market Share by Countries in 2019
Figure 44. Americas Antifungal Drugs Consumption Market Share by Type in 2019
Figure 45. Americas Antifungal Drugs Consumption Market Share by Application in 2019
Figure 46. United States Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 47. United States Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 48. Canada Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 49. Canada Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 50. Mexico Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 51. Mexico Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 52. APAC Antifungal Drugs Consumption Market Share by Countries in 2019
Figure 53. APAC Antifungal Drugs Value Market Share by Regions in 2019
Figure 54. APAC Antifungal Drugs Consumption Market Share by Type in 2019
Figure 55. APAC Antifungal Drugs Consumption Market Share by Application in 2019
Figure 56. China Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 57. China Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 58. Japan Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 59. Japan Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 60. Korea Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 61. Korea Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 62. Southeast Asia Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 63. Southeast Asia Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 64. India Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 65. India Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 66. Australia Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 67. Australia Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 68. Europe Antifungal Drugs Consumption Market Share by Countries in 2019
Figure 69. Europe Antifungal Drugs Value Market Share by Countries in 2019
Figure 70. Europe Antifungal Drugs Consumption Market Share by Type in 2019
Figure 71. Europe Antifungal Drugs Consumption Market Share by Application in 2019
Figure 72. Germany Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 73. Germany Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 74. France Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 75. France Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 76. UK Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 77. UK Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 78. Italy Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 79. Italy Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 80. Russia Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 81. Russia Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 82. Middle East & Africa Antifungal Drugs Consumption Market Share by Countries in 2019
Figure 83. Middle East & Africa Antifungal Drugs Value Market Share by Countries in 2019
Figure 84. Middle East & Africa Antifungal Drugs Consumption Market Share by Type in 2019
Figure 85. Middle East & Africa Antifungal Drugs Consumption Market Share by Application in 2019
Figure 86. Egypt Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 87. Egypt Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 88. South Africa Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 89. South Africa Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 90. Israel Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 91. Israel Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 92. Turkey Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 93. Turkey Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 94. GCC Countries Antifungal Drugs Consumption Growth 2015-2020 (K Units)
Figure 95. GCC Countries Antifungal Drugs Value Growth 2015-2020 ($ Millions)
Figure 96. Global Antifungal Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 97. Global Antifungal Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 98. Americas Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 99. Americas Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 100. APAC Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 101. APAC Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 102. Europe Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 103. Europe Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 104. Middle East & Africa Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 105. Middle East & Africa Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 106. United States Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 107. United States Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 108. Canada Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 109. Canada Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 110. Mexico Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 111. Mexico Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 112. Brazil Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 113. Brazil Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 114. China Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 115. China Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 116. Japan Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 117. Japan Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 118. Korea Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 119. Korea Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 120. Southeast Asia Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 121. Southeast Asia Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 122. India Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 123. India Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 124. Australia Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 125. Australia Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 126. Germany Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 127. Germany Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 128. France Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 129. France Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 130. UK Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 131. UK Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 132. Italy Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 133. Italy Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 134. Russia Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 135. Russia Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 136. Spain Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 137. Spain Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 138. Egypt Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 139. Egypt Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 140. South Africa Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 141. South Africa Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 142. Israel Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 143. Israel Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 144. Turkey Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 145. Turkey Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 146. GCC Countries Antifungal Drugs Consumption 2021-2025 (K Units)
Figure 147. GCC Countries Antifungal Drugs Value 2021-2025 ($ Millions)
Figure 148. Novartis Antifungal Drugs Market Share (2018-2020)
Figure 149. J & J Antifungal Drugs Market Share (2018-2020)
Figure 150. Pfizer Antifungal Drugs Market Share (2018-2020)
Figure 151. Merck Antifungal Drugs Market Share (2018-2020)
Figure 152. Enzon Pharmaceuticals Antifungal Drugs Market Share (2018-2020)
Figure 153. Sanofi Antifungal Drugs Market Share (2018-2020)
Figure 154. GlaxoSmithKline Antifungal Drugs Market Share (2018-2020)
Figure 155. Bayer Antifungal Drugs Market Share (2018-2020)
Figure 156. Abbott Antifungal Drugs Market Share (2018-2020)
Figure 157. Astellas Pharma Antifungal Drugs Market Share (2018-2020)
Figure 158. Teva Antifungal Drugs Market Share (2018-2020)
Figure 159. Mylan Antifungal Drugs Market Share (2018-2020)